Evidence map›Paper›PMID 32580136›Full record

ArticleEBioMedicine2020

Extremely low viral reservoir in treated chronically HIV-1-infected individuals.

Cristina Gálvez, Victor Urrea, Judith Dalmau, Montse Jimenez, Bonaventura Clotet, Valérie Monceaux, Nicolas Huot, Lorna Leal, Victoria González-Soler, Maria González-Cao and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02972931 (Impact of Antiretroviral Treatment and Predictors in Subjects With Extremely Low HIV-1 Reservoir), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02972931 completednot on this map

Impact of Antiretroviral Treatment and Predictors in Subjects With Extremely Low HIV-1 Reservoir: Optimization of New Cure Strategies

TypeobservationalSponsorIrsiCaixaRan2018 to 2019Enrolled62ConditionsHiv
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Tenofovir disoproxil fumarate mediates neuronal injury by inducing neurotoxicity.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Cristina GálvezIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain; Autonomous University of Barcelona, Cerdanyola del Vallés, Spain.
Victor UrreaIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Judith DalmauIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Montse JimenezIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain; Autonomous University of Barcelona, Cerdanyola del Vallés, Spain.
Bonaventura ClotetIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain; Autonomous University of Barcelona, Cerdanyola del Vallés, Spain; 'Lluita contra la SIDA' Foundation, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.
Valérie MonceauxInstitut Pasteur, Unité HIV Inflammation et Persistance, Paris, France.
Nicolas HuotInstitut Pasteur, Unité HIV Inflammation et Persistance, Paris, France.
Lorna LealInfectious Diseases Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Victoria González-SolerCentre for Epidemiological Studies on Sexually Transmitted Diseases and HIV/AIDS of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Spain; Microbiology Department. Laboratori Clínic Metropolitana Nord. University Hospital "Germans Trias i Pujol", Badalona, Spain. Department of Genetics and Microbiology. Autonomous University of Barcelona, Spain; CIBER Epidemiologia y Salud Publica (CIBERESP), Spain.
Maria González-CaoTranslational Cancer Research Unit, Instituto Oncológico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.
Michaela Müller-TrutwinInstitut Pasteur, Unité HIV Inflammation et Persistance, Paris, France.
Asier Sáez-CiriónInstitut Pasteur, Unité HIV Inflammation et Persistance, Paris, France.
Felipe GarcíaInstitut Pasteur, Unité HIV Inflammation et Persistance, Paris, France.
Julià BlancoIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.
Javier Martinez-PicadoIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. Electronic address: jmpicado@irsicaixa.es.
Maria SalgadoIrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain. Electronic address: msalgado@irsicaixa.es.
Institut Pasteur · FRIrsiCaixa · ESUniversitat Autònoma de Barcelona · ESUniversitat de Vic - Universitat Central de Catalunya · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESInstituto Oncológico Dr. Rosell · ES

Funding

Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid FolliclesR01AI143457 · NIAID · DUKE UNIVERSITY · PI REEVES, ROGER KEITH · 2019 to 2023
$3.1M
NIAID NIH HHS R01 AI143457
6 · The paper itself

Abstract

backgroundSmall viral reservoirs are found predominantly in HIV-1 controllers and individuals treated during acute/early HIV-1 infection. However, other HIV

methodsWe screened 451 HIV-1-infected treated-individuals with suppressed plasma viremia for at least 3 years and stored cryopreserved peripheral blood mononuclear cells (PBMCs). Total HIV-DNA was analysed in PBMCs with ddPCR. Individuals with <50 HIV-DNA copies/10

findingsWe found that 9.3% of the individuals screened had <50 HIV-DNA copies/10

interpretationTreated chronically HIV-1-infected LoViReT represent a new phenotype of individuals characterized by an intrinsically reduced viral reservoir, less impaired CD8

fundingMSD Spain.

Indexed as

AdultAnti-HIV AgentsCD4-Positive T-LymphocytesDisease ReservoirsHIV-1HIV InfectionsHumansLeukocytes, MononuclearMaleSpainViral LoadViremiaAnti-HIV AgentsHIV latencyHIV reservoirHIV-specific antibodiesimmunophenotypingtotal HIV-DNA

Identifiers

PMID32580136
PMCPMC7317241
OpenAlexW3036745675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.